SUMMARY In a controlled prospective double blind trial patients with cholesterol gall bladder stones are treated with ursodeoxy-cholic acid (group A: UDCA 11 1 mg/kg per day; n=16) and Ursomenth respectively (group B: a mixture of UDCA/menthol: 4.75 mg/kg per day each; n=17). With same stone number and size (10-12 mm) there is a complete dissolution rate in group A of 38%, and of 53% in group B within 15-16-9 months. The response rate (complete+partial dissolution) amounted to 75% and 76% respectively. In group A there is one case of stone calcification, in group B none. Both preparations are free of unwanted effects. This suggests that the cyclic monoterpene menthol enhances the effect of UDCA and is of comparable effect to a mixture of six different terpenes used in former times.
In 1979 Bell and Doran' reported the treatment of 24 patients with cholesterol stones of the gall bladder and the bile ducts with Rowachol(R)*, one capsule/10 kg/day. After six to 12 months the stones had dissolved in four patients partially and in three patients completely. In 19812 the same group reported on Rowachol treatment of 13 patients with bile duct stones. In eight of 13 patients the concrements had vanished. In 1984 the authors' administered Rowachol (one capsule twice daily) plus 7-0-10-5 mg/kg/day chenodeoxycholic acid (CDCA) to 29 patients with gall stones. After two years the stones were completely dissolved in 15 patients. Finally in 1985 the same group4 reported on the treatment of 19 Dissolution ofgallstones with an ursodeoxycholic acid mentholpreparation Patients weighing less than 50 kg received two capsules UDCA of 250 mg or Ursomenth at bedtime. From 50-75 kg we gave one capsule at noon, two capsules at bedtime. In cases of 75-100 kg body weight we gave one capsule at noon and three capsules at bedtime. Cases of 100-125 kg received one capsule at noon and four at bedtime. The mean UDCA dosage amounted to 11-1 mg/kg per day; the tNeither the Ames test nor the DNA repair test (National Cancer Institute, USA) gave any indication of carcinogenic effect. Tables 3 and 4 . Both types of medication were free from unwanted effects. Laboratory tests were comparable in all groups. Apart from colic we noticed a rise in SGOT, SGPT, AP, or GGT of short duration. In almost all patients complaints decreased considerably and disappeared completely in the end. In group B one patient developed severe colic, he underwent surgery, and was classified as a non-responder.
Discussion
Ursomenth induced in 53% of those patients treated complete stone dissolution, UDCA in 38%. When the percentage of partial stone dissolution is addedwhich we did not consider as therapeutic successthen the response rate in group A amounted to 75% and in group B to 76%. In other words the result is almost identical for both types of medication. It is unlikely that the Ursomenth result can be ascribed to the UDCA portion in Ursomenth alone. This would mean that 4 8 mg UDCA/kg per day corresponded to the 2-3-fold higher dosage of 11 mg UDCA/kg/day. The Franco-Belgian study group75 has shown, however, that already a UDCA dosage of 8 4 mg/kg/day can significantly improve the dissolution rate compared with the half dosage of 4.2 mg/kg/day.7 This is in keeping with results of Dowling et al9 who showed in 55 responders that the optimal dosage is 9 6 Furthermore, Rowachol has a choleretic effect and it is said to be a non-specific enzyme inducer." Igimi et al and ourselves2" reported that the terpenes d-limonene and cineol would dissolve cholesterol stones in vitro too and thus the effect described by Clegg et al'8 for terpenes on HMG-CoA reductase is obviously not their only effect.
Whether the UDCA/menthol mixture will achieve an equally favourable dissolution rate in larger stones as UDCA monotherapy still has to be investigated in a considerably larger number of patients. The promising results discussed here in stones of an average of 10-12 mm suggest at least that UDCA/ menthol might be useful for recurrence prophylaxis. Stone recurrence after UDCA treatment is found in 20-50%222 and therefore a cheap preparation for longterm treatment is needed without unwanted effects. 
